DBISX
Price
$12.01
Change
-$0.03 (-0.25%)
Updated
Jun 2 closing price
Net Assets
181.67M
MBXIX
Price
$45.82
Change
-$0.15 (-0.33%)
Updated
Jun 2 closing price
Net Assets
10.13B
Interact to see
Advertisement

DBISX vs MBXIX

Header iconDBISX vs MBXIX Comparison
Open Charts DBISX vs MBXIXBanner chart's image
DBISX vs MBXIX Comparison Chart in %
View a ticker or compare two or three
VS
DBISX vs. MBXIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBISX is a Buy and MBXIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXIX has more cash in the bank: 10.1B vs. DBISX (182M). DBISX pays higher dividends than MBXIX: DBISX (1.74) vs MBXIX (0.00). DBISX was incepted earlier than MBXIX: DBISX (25 years) vs MBXIX (10 years). MBXIX (2.00) is less costly to investors than DBISX (1.31). MBXIX is a more actively managed with annual turnover of: 19.00 vs. DBISX (12.00). DBISX has a lower initial minimum investment than MBXIX: DBISX (1000) vs MBXIX (2500). MBXIX annual gain was more profitable for investors over the last year : 21.36 vs. DBISX (12.93). MBXIX return over 5 years is better than : 37.51 vs. DBISX (23.44).
DBISXMBXIXDBISX / MBXIX
Total Expense Ratio1.122.0056%
Annual Report Gross Expense Ratio1.312.0066%
Fund Existence25 years10 years-
Gain YTD4.22013.47831%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets182M10.1B2%
Annual Yield % from dividends1.740.00790,464%
Returns for 1 year12.9321.3661%
Returns for 3 years27.3538.0572%
Returns for 5 years23.4437.5162%
Returns for 10 years69.29106.1065%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGFX25.07N/A
N/A
Morgan Stanley Inst Global Franchise C
TQTIX19.85N/A
N/A
AMG TimesSquare International SmallCap I
ARAQX9.98N/A
N/A
Aristotle Value Eq A
PACLX37.16N/A
N/A
T. Rowe Price Capital Appreciation Adv
TSCHX23.16N/A
N/A
Nuveen Quant Small Cap Equity I